Literature DB >> 25349101

SALL4 positive fetal gut-like adenocarcinoma of the duodenum.

Shoichi Kinoshita1, Masayuki Sho, Yasunori Enomoto, Fumikazu Koyama, Takahiro Akahori, Minako Nagai, Masahiro Ito, Kohei Morita, Chiho Ohbayashi, Yoshiyuki Nakajima.   

Abstract

Fetal gut-like adenocarcinoma is a rare carcinoma, previously reported in the stomach, which features clear cytoplasm cell papillotubular carcinoma and morphology similar to the fetal gut epithelium. SALL4, a novel marker for progenitor-type tumors, has shown high expression in fetal gut-like adenocarcinoma, which may represent oncofetal protein expression and fetal differentiation. Herein, we report the first case of fetal gut-like adenocarcinoma of the duodenum. An 81-year-old man was admitted on account of jaundice. A deeply ulcerating duodenal tumor formed a 4 cm periampullar mass. Pancreatoduodenectomy with lymphadenectomy was performed. Funicular and solid growth of clear cytoplasmic cells that resembled the fetal gut epithelium formed a poorly differentiated adenocarcinoma. Lymph node metastasis was present. Immunohistochemistry analysis showed diffuse nuclear positivity for SALL4. For postoperative therapy, S-1 was administered. The patient is alive with no recurrence, 83 months postoperatively. This case may contribute to further elucidate the disease entity of SALL4 positive, fetal-type carcinomas.
© 2014 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  SALL4; duodenum; fetal gut-like adenocarcinoma

Mesh:

Substances:

Year:  2014        PMID: 25349101     DOI: 10.1111/pin.12211

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  1 in total

1.  SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway.

Authors:  Chuanjin Liu; Haibin Wu; Yanyan Li; Liang Shen; Renchun Yu; Hongwei Yin; Ting Sun; Chunming Sun; Youxin Zhou; Ziwei Du
Journal:  J Neurooncol       Date:  2017-09-08       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.